Uptravi (selexipag)

pCPA File Number: 20960

Negotiation Status:

Concluded with an LOI

Indication(s):

Pulmonary Arterial Hypertension

Sponsor/Manufacturer:

Actelion Pharmaceuticals Ltd.

CDA-AMC Project Number:

SR0482-000

pCPA Engagement Letter Issued:

2017-04-13

Negotiation Process Concluded:

2017-12-12